South Korea vs Least Developed Countries (LDCs): Proportion of the target population … measles-containing-vaccine
South Korea
96.0%
in 2024
Least Developed Countries (LDCs)
58.0%
in 2024
South Korea rank
28th
Least Developed Countries (LDCs) rank
31st
Proportion of the target population … measles-containing-vaccine over time
- South Korea
- Least Developed Countries (LDCs)
How they compare
South Korea currently reports 96.0% against 58.0% in Least Developed Countries (LDCs), a difference of 38.0%.
That makes South Korea's figure about 1.7 times Least Developed Countries (LDCs)'s.
Across all 24 years both countries report, South Korea has been ahead every year.
South Korea ranks 28th and Least Developed Countries (LDCs) ranks 31st of 195 countries.
South Korea has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | South Korea | Least Developed Countries (LDCs) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.6% | 1.4% | 93.1% | South Korea |
| 2010s | 96.8% | 24.6% | 72.2% | South Korea |
| 2020s | 95.4% | 48.6% | 46.8% | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, South Korea or Least Developed Countries (LDCs)?
- South Korea, at 96.0% against 58.0% in Least Developed Countries (LDCs) as of 2024.
- What is the difference in proportion of the target population who received between South Korea and Least Developed Countries (LDCs)?
- 38.0%, with South Korea ahead.
- How many years of comparable data are there for South Korea and Least Developed Countries (LDCs)?
- 24 years are reported by both, from 2001 to 2024.
- How do South Korea and Least Developed Countries (LDCs) rank globally for proportion of the target population who received?
- South Korea ranks 28th and Least Developed Countries (LDCs) ranks 31st of 195 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.